Find a Faculty

Gold Divider 4Col
Physician Photo

Business Offices

Address
Annenberg Building Floor 16 Room 16-64
1468 Madison Avenue
New York, NY 10029
Tel
212-241-5576
Fax
212-534-1684

Matthew J. Evans

ASSISTANT PROFESSOR  Microbiology

Overview

Gender Male
E-mail matthew.evans@mssm.edu
Education and Training Ph.D., Columbia University
  Postdoctoral Fellowship, The Rockefeller University

Our group is interested in the fundamental question concerning how viruses identify and enter suitable host cells. Although, as described below, we are currently focusing on hepatitis C virus (HCV) entry, we intend to pursue similar studies on the entry mechanisms of other viruses, such as the related Dengue and Yellow Fever viruses, or even more disparate viruses, including Ebola and HIV.

Our first goal is the identification of the host cell machinery required for viral entry. For HCV, entry is exclusively restricted to hepatocytes. This suggests that these cells express required factors not present in other cells. To identify such factors we conducted a complementation screen, where an HCV permissive cell cDNA library was screened for genes capable of rendering a nonpermissive cell HCVpp infectable. In this manner we identified Claudin-1, a component of the tight junction (TJ) required to seal off the basolateral and apical spaces of polarized epithelial cells, as an essential HCV receptor (Evans et al., Nature 2007). We are currently performing a similar screen to identify human genes able to confer HCV susceptibility to murine cells. Successful identification of such factors would be a major step towards the development of new mouse models. We also intend to carryout siRNA and small molecular screens as alternative means to identify additional the cellular machinery required for HCV entry.

The identification of CLDN1 as an essential HCV entry factor suggests that cell polarity may be an important aspect of the HCV entry process. We are utilizing polarized cell models to study HCV entry in this specialized setting. The mechanisms of this process can be probed by the addition of inhibitors specific for each entry factor to determine how they are utilized by the incoming virus. We also wish to visualize the HCV entry process by fluorescently labeling host and viral entry factors and observed their localization during infection.

Training

Education and Training Ph.D., Columbia University
  Postdoctoral Fellowship, The Rockefeller University

Publications

Tscherne DM, Evans MJ, MacDonald MR, Rice CM, . Transdominant inhibition of bovine viral diarrhea virus entry. J Virol 2008; 82(5): 2427-2436.


Stamataki Z, Coates C, Evans MJ, Wininger M, Crawford K, Dong C, Fong Y, Chien D, Abrignani S, Balfe P, Rice CM, McKeating JA, Houghton M, . Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine 2007; 25(45): 7773-7784.


Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM, . Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446(7137): 801-805.


Tellinghuisen T, Evans MJ, von Hahn T, You S, Rice CM. Studying hepatitis C - making the best out of a bad virus. J Virol 2007; 81(17): 8853-8867.


McMullan LK, Grakoui A, Evans MJ, Mihalik K, Puig M, Branch AD, Feinstone SM, Rice CM, . Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U.S.A. 2007; 104(8): 2879-2884.


Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007; 81(8): 3693-3703.


Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. Time and temperature dependent activation for hepatitis C virus low pH triggered entry. J Virol 2006; 80(4): 1734-1741.


Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM, . Complete replication of hepatitis C virus in cell culture. Science 2005; 309(5734): 623-626.


Mark-Danieli M, Laham N, Kenan-Eichler M, Castiel A, Melamed D, Landau M, Bouvier NM, Evans MJ, Bacharach E. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity. J Virol 2005; 79(12): 7756-7767.


Evans MJ, Rice CM, Goff SP. Genetic interactions between hepatitis C virus replicons. J Virol 2004; 78(21): 12085-12089.


Institutes, Centers, Programs and Laboratories

The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.

Clinical Trials

Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.

(800) MD-SINAI (800) 637-4624

Visit Mount Sinai Queens